Tilray shares technical analysis: Persistent seller pressure keeps downside risk in focus

Tilray shares technical analysis: Persistent seller pressure keeps downside risk in focus
Tilray drops 4.75% to $2.51 today

Tilray (TLRY) stock is trading at $2.51 after falling 4.75% on the day. The price remains below its key moving averages, signaling ongoing downside momentum.

TLRY price prediction
24H -0.4%
$2.52
48H -1.19%
$2.5
7D -1.19%
$2.5
1M -45.45%
$1.38
3M -59.68%
$1.02
6M -74.31%
$0.65
12M -84.98%
$0.38
Current price: $2.53 -0.1000 3.80%
Closed 10/30
Daily range 2.49 Arrow from to Icon 2.67
Weekly range 2.49 Arrow from to Icon 2.80
Loading...

Highlights

  • Tilray Brands consolidated its U.S. brewing operations from 10 to 6 facilities to achieve $20 million in annual cost savings by fiscal 2028.
  • The company reaffirmed its fiscal 2027 Adjusted EBITDA guidance of $68 million to $75 million and will begin brewing Carlsberg products in the U.S. from January 2027.
  • Shares of Tilray Brands remain under heavy downside pressure, trading below key moving averages with technical indicators confirming a strong sell bias and an expected near-term range of $2.42 to $2.59.

Cost-cutting and expansion bets offset by persistent selling pressure

Tilray Brands has completed the consolidation of its U.S. brewing operations from 10 to 6 facilities, a move expected to reduce overhead and improve operational efficiency, according to Biopharmawatch. This restructuring targets approximately $20 million in annual cost savings by fiscal 2028 and is paired with the company’s reaffirmed fiscal 2027 Adjusted EBITDA guidance of $68 million to $75 million. Tilray Brands is also planning to begin brewing and distributing Carlsberg products in the U.S. from January 2027, supporting its expansion in the beverage segment, as reported by Proactiveinvestors. These developments indicate strong progress on cost management and growth initiatives, though price action has remained under broader selling pressure.

Tilray Brands Inc. asset chart
Tilray Brands Inc. price dynamics. Source: TradingView.

Key resistances cap price as technical signals reinforce downside

On the technical side, TLRY is trading below the MA-20 at $2.63 and the MA-50 at $2.75 on the working timeframe, while remaining significantly beneath the MA-200 at $5.51. The Ichimoku Kijun level at $2.66 stands as immediate resistance; short-term support is identified near $2.42. Downside momentum is reinforced by MACD and ADX, both showing a pronounced sell bias. RSI is deep in oversold territory at 28.58, a signal echoed by Stochastic RSI and CCI, which confirm the oversold environment, while Bull/Bear Power and the Awesome Oscillator also indicate persistent seller control.

Limited rebound prospects amid aligned negative momentum indicators

Over the next two to three trading days, TLRY is expected to trade in a range between $2.42 and $2.59. The likelihood of a rebound is minimal, as technical and momentum indicators remain firmly aligned to the downside, making an upward reversal highly unlikely. The baseline expectation is for sideways price movement within this range amid high volatility. If TLRY breaks above $2.66, this would trigger a bullish scenario, while a sustained drop below $2.42 would indicate the potential for further losses.

Anton Kharitonov, expert at Traders Union, sees continued downside for TLRY despite recent operational improvements. He notes the business restructuring and reaffirmed guidance but emphasizes that technical signals remain strongly bearish. Key levels at $2.66 (resistance) and $2.42 (support) frame the tactical range. "Until TLRY breaks above $2.66, I remain defensive and see limited chance for a meaningful rebound in the near term."

Earlier, analysts noted that Tilray faced persistent downside risk amid ongoing technical weakness. The latest developments reinforce this bearish outlook, with traders advised to closely monitor the $2.42 support level for signs of either stabilization or renewed losses.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.